Brief: Achilles Therapeutics Announces Pricing Of Initial Public Offering
31/03/2021 24:18
March 30 (Reuters) - Achilles Therapeutics PLC ACHL.O :
* ACHILLES THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC
OFFERING
* PRICING OF ITS IPO IN U.S. OF 9,750,000 AMERICAN
DEPOSITARY
SHARES AT PRICE OF $18.00 PER ADS
Source text for Eikon: ID:nGNX597CD
Further company coverage: ACHL.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement